PDCD1 and neoplasm: Our findings affect the m6A-related gene YTHDF1 and dendritic cells in immunity, and METTL3 enhanced the response to anti-PD-1 treatment [51], which suggests that these lncRNAs enhance the effect of tumor immunotherapy by regulating m6A-related target genes.